Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
CALL
Boston Scientific
BSX
$61.7B
| $3.38M | ﹤0.01% |
31,500
-47,500
| -60% | -$4.81M |
2024 Q2
4 quarters
|
|
2402
CALL
GitLab
GTLB
$8.29B
| $3.38M | ﹤0.01% |
75,000
-169,600
| -69% | -$7.76M |
2025 Q1
1 quarter
|
|
2403
LeMaitre Vascular
LMAT
$1.81B
| $3.38M | ﹤0.01% |
40,726
+12,177
| +43% | +$1.02M |
2017 Q1
33 quarters
|
|
2404
Autoliv
ALV
$8.19B
| $3.38M | ﹤0.01% |
30,215
-12,074
| -29% | -$1.18M |
2013 Q2
48 quarters
|
|
|
NBIS
2405
PUT
Nebius Group N.V.
NBIS
$66B
| $3.38M | ﹤0.01% |
61,100
-474,000
| -89% | -$16.3M |
2025 Q1
1 quarter
|
|
|
KKR.PRD
2406
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.12B
| $3.38M | ﹤0.01% |
63,040
-23,380
| -27% | -$1.15M |
2025 Q1
1 quarter
|
|
2407
Leonardo DRS
DRS
$9.82B
| $3.38M | ﹤0.01% |
72,649
-169,686
| -70% | -$6.81M |
2023 Q1
9 quarters
|
|
2408
United Natural Foods
UNFI
$2.75B
| $3.38M | ﹤0.01% |
144,808
+55,786
| +63% | +$1.45M |
2013 Q2
48 quarters
|
|
2409
American Eagle Outfitters
AEO
$2.97B
| $3.37M | ﹤0.01% |
350,715
+97,627
| +39% | +$1.05M |
2013 Q2
48 quarters
|
|
2410
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.24B
| $3.37M | ﹤0.01% |
56,361
+20,450
| +57% | +$1.17M |
2013 Q2
48 quarters
|
|
2411
National Vision
EYE
$1.3B
| $3.36M | ﹤0.01% |
146,080
+46,894
| +47% | +$800K |
2017 Q4
30 quarters
|
|
2412
Northwest Natural Holdings
NWN
$1.99B
| $3.36M | ﹤0.01% |
84,612
+27,138
| +47% | +$1.13M |
2013 Q2
48 quarters
|
|
2413
Diamondrock Hospitality Co
DRH
$2.57B
| $3.35M | ﹤0.01% |
437,927
+167,315
| +62% | +$1.25M |
2013 Q2
48 quarters
|
|
2414
Immunocore
IMCR
$1.53B
| $3.35M | ﹤0.01% |
106,862
-228
| -0.2% | -$7.08K |
2022 Q1
13 quarters
|
|
2415
Phreesia
PHR
$625M
| $3.35M | ﹤0.01% |
117,751
-68,596
| -37% | -$1.74M |
2022 Q1
13 quarters
|
|
|
VNET
2416
VNET Group
VNET
$1.46B
| $3.35M | ﹤0.01% |
485,481
-116,818
| -19% | -$700K |
2020 Q2
20 quarters
|
|
2417
CALL
Valaris
VAL
$5.44B
| $3.34M | ﹤0.01% |
79,400
| – | – |
2025 Q1
1 quarter
|
|
|
2418
PUT
Valaris
VAL
$5.44B
| $3.34M | ﹤0.01% |
79,400
| – | – |
2025 Q1
1 quarter
|
|
2419
Minerals Technologies
MTX
$2.07B
| $3.34M | ﹤0.01% |
60,597
+18,849
| +45% | +$1.06M |
2013 Q2
48 quarters
|
|
2420
Enovix
ENVX
$614M
| $3.33M | ﹤0.01% |
367,993
+125,242
| +52% | +$817K |
2022 Q1
13 quarters
|
|
2421
Amneal Pharmaceuticals
AMRX
$7.07B
| $3.33M | ﹤0.01% |
411,531
+124,161
| +43% | +$936K |
2018 Q2
28 quarters
|
|
2422
Sunstone Hotel Investors
SHO
$2.12B
| $3.33M | ﹤0.01% |
383,493
-224,440
| -37% | -$1.93M |
2013 Q2
48 quarters
|
|
2423
Sylvamo
SLVM
$1.29B
| $3.33M | ﹤0.01% |
66,415
+13,834
| +26% | +$779K |
2022 Q1
13 quarters
|
|
|
2424
PUT
GitLab
GTLB
$8.29B
| $3.32M | ﹤0.01% |
73,700
+28,700
| +64% | +$1.31M |
2025 Q1
1 quarter
|
|
2425
CALL
Array Technologies
ARRY
$628M
| $3.32M | ﹤0.01% |
+562,500
| New | +$3.42M |
2025 Q2
0 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.